8 min read

PCOS is now PMOS: understanding the new name

The condition long known as PCOS is now increasingly referred to as PMOS, reflecting a broader understanding of its hormonal and metabolic nature.

Author: Dr. Nithanth Balshyam

For many years, Polycystic Ovary Syndrome, commonly known as PCOS, was the term used to describe a common hormonal disorder affecting women of reproductive age. As scientific understanding improved, experts recognized that the condition involves much more than the ovaries alone.

The newer term PMOS, or Polyendocrine Metabolic Ovarian Syndrome, reflects the wider hormonal and metabolic effects seen in affected individuals. The change aims to improve understanding and reduce misconceptions associated with the older name.

Why the name PCOS was considered incomplete

The term Polycystic Ovary Syndrome led many people to believe that ovarian cysts were the defining feature of the condition. However, many women diagnosed with the disorder do not have ovarian cysts, while some women with polycystic-appearing ovaries do not have the syndrome.

Researchers and clinicians increasingly felt that the old terminology failed to represent the full picture. The condition affects hormone regulation, metabolism, insulin sensitivity, menstrual function and fertility, making it much broader than a simple ovarian disorder.

What PMOS stands for

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. The term polyendocrine highlights the involvement of multiple hormonal systems. Metabolic reflects the important role of insulin resistance and related metabolic disturbances. Ovarian remains part of the name because reproductive and ovulatory dysfunction continue to be important features.

The word syndrome indicates that symptoms vary considerably between individuals. Some patients mainly experience menstrual irregularities, while others are more troubled by weight changes, acne, excess facial hair, fertility concerns or metabolic issues.

Common symptoms associated with PMOS

Patients may report irregular menstrual cycles, delayed ovulation, acne, unwanted facial hair growth, scalp hair thinning, weight gain, difficulty losing weight and fertility concerns. Symptoms often develop gradually and may vary in intensity over time.

Not every patient experiences the same pattern. Some individuals seek medical advice mainly for cycle irregularities, while others first notice skin changes, weight gain or difficulties conceiving. This variation is one reason the condition can sometimes be overlooked.

The metabolic side of the condition

One of the most important advances in recent research has been the recognition of insulin resistance as a major component of PMOS. Elevated insulin levels may contribute to hormonal imbalance and can influence weight regulation, energy levels and reproductive health.

Because of these metabolic effects, patients may also have an increased risk of prediabetes, Type 2 diabetes, abnormal cholesterol levels and other long-term health concerns. This broader understanding is one of the reasons the newer terminology includes the word metabolic.

What the name change means for patients

The name change does not mean that patients have a new disease or that existing diagnoses become invalid. Instead, it reflects a more accurate scientific understanding of the condition and encourages a more comprehensive approach to evaluation and management.

Patients should continue regular medical follow-up, pay attention to lifestyle factors such as diet, exercise and sleep, and seek professional guidance when symptoms affect daily life, fertility goals or overall wellbeing.

Frequently asked questions

Has PCOS been completely replaced by PMOS?

Many experts and professional groups now support the term PMOS because it better reflects current scientific understanding, although PCOS remains widely recognized by patients and healthcare providers.

Does PMOS always involve ovarian cysts?

No. Many affected women do not have ovarian cysts, which was one of the major reasons for reconsidering the older terminology.

Why is the word metabolic included in PMOS?

Research has shown that insulin resistance and metabolic disturbances are common features and can influence many symptoms associated with the condition.

Does the name change affect treatment?

The name change itself does not alter treatment. It primarily helps improve understanding of the condition and encourages a broader view of patient care.

Kanhangad clinic Kasaragod district Patient education Consultation guidance

About the Author

Dr. Nithanth B.S. is Homoeopathic Physician and Medical Officer, Hahnemann Homoeos.

Dr. Nithanth Balshyam is a homoeopathic physician and Medical Officer at Hahnemann Homoeos, Vanila Square, Kanhangad. Patients looking for a homeo doctor in Kanhangad, homoeo doctor in Kanhangad or a homoeopathic clinic near Kottachery often reach the clinic for consultation, patient education and community health outreach across Kasaragod district.

Hahnemann Homoeos at Vanila Square, Kanhangad serves patients from Kanhangad, Kasaragod, Nileshwar, Cheruvathur, Bekal and nearby areas. Dr. Nithanth Balshyam is associated with clinic-based consultation, educational health writing and outreach activity for families searching for experienced homoeo doctors in Kanhangad and surrounding parts of Kasaragod district.

Read full author profile

Need a consultation?

Call or WhatsApp the clinic if you need an appointment or want to ask about visit timings.